Last Updated: 05/19/2015 08:14:55
AVEW Stock Chart - 1 Month
AVEW Stock Chart - 3 Month
AVEW Stock Chart - 6 Month
AVEW Stock Chart - 1 Year
AVEW Stock Chart - 2 Year
AppLovin's Fall from Grace AppLovin Corporation's recent tumble from investor darling to beleaguered party in a securities class action isn’t just a misstep; it’s a full-fledged nosedive into troubled waters that no trader worth their salt would want to ignore. The story kicks off with a pair of sharply disappointing turns that sent shivers down the spines of anyone...
Continue Reading
Docusign Brings Its A-Game with SAP Partnership Waking up to find Docusign (NASDAQ:DOCU) teaming up with SAP is like getting a surprise deal at the Saturday market—unexpected but welcome. These two giants in their respective fields are joining forces to plant Docusign’s Intelligent Agreement Management (IAM) directly into SAP Sales Cloud and SAP SuccessFactors. If...
Continue Reading
Elbit Systems Secures Major Asia-Pacific Deal You know, it's not every day that a defense contractor like Elbit Systems (NASDAQ:ESLT) bags a $200 million deal in the Asia-Pacific region. A big move in a high-stakes game where technology, strategy, and geography collide. This isn't some random supply deal; this involves the cutting edge of defense tech—ISTAR and training...
Continue Reading
A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...
Continue Reading
The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...
Continue Reading
In today's cutthroat retail world, where every dollar counts, you won't see many shops in a rush to shutter their doors on a busy shopping day unless they mean business. So here's a rare bird: P.C. Richard & Son, the family-owned retail stalwart, has a different tune to hum amid the holiday hustle—closing every single one of their 63 stores for Thanksgiving. Figure...
Continue Reading
Shenzhen Steps into the Arbitration Spotlight In a move that's bound to tweak some eyebrows in the legal realm, Shenzhen just hosted the 2026 Foreign Direct Investment International Arbitration Moot (FDI Moot) Global Finals. This marks the first time the finals have landed on Chinese soil, and folks, that's a big deal. It’s a hefty nod to China's expanding credibility...
Continue Reading
Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...
Continue Reading
Ah, the holidays—they're creeping up like a kid sneaking downstairs for a peek at their gifts. But it's not the gifts under the tree that brighten a room, it's those lights draping the tree itself. Enter Govee, bringing us back to that vintage glow we all remember from our childhoods. They've teamed up with Brady Tolbert, a design whiz who can make a living room look...
Continue Reading
AVANT BIO's Latest Power Play Alright, here's a big splash in the gene pool of life sciences—AVANT BIO just drafted two industry veterans, Peggy Lio and Philip Vanek, into their Operating Advisor Hall of Fame. And these folks aren't just window dressing. They're packing experience from some of the big hitters like GE Healthcare and Lonza, ready to roll up their sleeves...
Continue Reading
Allucent Strengthens Leadership to Propel Drug Development Allucent, a prominent global science-centered contract research organization (CRO), has announced a significant expansion of its executive team to enhance its drug development capabilities for biopharmaceutical clients. This strategic move comes as the organization aims to reinforce its collaboration with small...
Continue Reading
What's Brewing with GeneDx? In the wild world of stocks, there's no shortage of hiccups and unforeseen hurdles. This time around, it's GeneDx Holdings Corp. (NASDAQ: WGS) making the news with a securities fraud class action docketed against it. If you played the WGS stock game between April 16, 2025, and May 4, 2026, you're smack in the middle of this whirlwind. The Drama...
Continue Reading
Signs of an Impending Breakout for D.R. Horton D.R. Horton, Inc. shares are on the rise, indicative of a potential breakout situation that could lead to the formation of a new uptrend in the company’s stock price. The Key to Breakouts This moment highlights D.R. Horton as a significant stock to watch. In financial markets, certain price levels are more crucial than...
Continue Reading
Transformative Growth in Parkinson’s Disease Therapeutics As we navigate the landscape of neurological disorders, the therapeutic domain for Parkinson's disease is poised for remarkable transformation. Recent analyses provide an optimistic outlook for the Parkinson’s disease market, with an expected growth period spanning from 2020 to 2034. The anticipated market...
Continue Reading
POET Technologies Partners with Mitsubishi Electric POET Technologies Inc. (NASDAQ: POET) has exciting news: they’re teaming up with Mitsubishi Electric Corporation. This partnership is set to create advanced integrated optical engine chipsets specifically for the new 3.2T pluggable transceivers. This cutting-edge innovation aims to boost optical connectivity,...
Continue Reading